Part: 12         Session: 145678910111213141516171819202122         Page 680681682683684685686687688689690691692693694695696697698699700701702703704705706707708709710711712713714715716717718719720721722723724725726727728729730731731a of 999

But the most exciting thing is that we visited Hoffman-LaRoche in June 1978, and they're busy about trying to make it commercially. And so is Merck, and so is Burroughs Wellcome. Now, whether they're going to be ready with anything in six months or in twelve months or eighteen months, I don't know, but it's certainly in that time span. If it's made commercially and purified, certainly the viral world will have a big challenge, and certainly it will be important to use with other drugs in cancer, and it might even prevent the onset of cancer. It might even be a prophylaxis against cancer. Now, that we just don't know, but it is in animals, a prophylaxis against the onset of naturally occurring cancer in mice. Naturally occurring leukemia in mice.

Well, anyway, that's the most exciting thing that we've done.

Well, that is exciting, and you've been right in the midst of it.

Well, I tell you, nothing would have been found out and nothing would have been done if I handn't been willing to put up this money, becuase this stunned the American Cancer Society. They couldn't believe that I would do this, just out of sheer frustration at not being able to get any money from other sources, you know, for the investigation of this material.

And it was that? It was in frustration, you wanted it done?